OMX Copenhagen PI
1.199,35
PKT
+23,69
PKT
+2,01
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Copenhagen PI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 13.07.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 07.07.16 | Novo Nordisk Hold | Kepler Cheuvreux | |
| 29.06.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 23.06.16 | Novo Nordisk buy | Citigroup Corp. | |
| 15.06.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 14.06.16 | Novo Nordisk buy | Citigroup Corp. | |
| 14.06.16 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 14.06.16 | Novo Nordisk Conviction Buy | Goldman Sachs Group Inc. | |
| 14.06.16 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 13.06.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 09.06.16 | Novo Nordisk overweight | Morgan Stanley | |
| 09.06.16 | Novo Nordisk buy | Baader Wertpapierhandelsbank | |
| 26.05.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 26.05.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 23.05.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 06.05.16 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.05.16 | Novo Nordisk buy | Citigroup Corp. | |
| 03.05.16 | Novo Nordisk Halten | Independent Research GmbH | |
| 03.05.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 02.05.16 | Novo Nordisk overweight | Barclays Capital | |
| 29.04.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 26.04.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 22.04.16 | Novo Nordisk overweight | Morgan Stanley | |
| 18.04.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 11.04.16 | Novo Nordisk Hold | Deutsche Bank AG | |
| 29.03.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 22.03.16 | Novo Nordisk overweight | Morgan Stanley | |
| 15.03.16 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 07.03.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 07.03.16 | Novo Nordisk overweight | Morgan Stanley | |
| 07.03.16 | Novo Nordisk Sell | UBS AG | |
| 07.03.16 | Novo Nordisk buy | Citigroup Corp. | |
| 07.03.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 02.03.16 | Novo Nordisk buy | Citigroup Corp. | |
| 24.02.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 24.02.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 22.02.16 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 16.02.16 | Novo Nordisk Neutral | BNP PARIBAS | |
| 15.02.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 09.02.16 | Novo Nordisk Halten | Independent Research GmbH |